Literature DB >> 19304944

Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.

Jingfang Sun1, Benjamin D Hopkins, Kaoru Tsujikawa, Carole Perruzzi, Irit Adini, Robert Swerlick, Paul Bornstein, Jack Lawler, Laura E Benjamin.   

Abstract

Microvascular development is often perceived to result from a balance of positive and negative factors that impact signaling for proliferation and survival. The survival signaling that results from hypoxia-induced VEGF-A has been well established, but the factors that antagonize this signaling have been poorly studied. As endogenous inhibitors of angiogenesis, thrombospondins (TSPs) are likely candidates to affect survival signaling. Here we report that TSP1 antagonized microvascular survival to retinal hyperoxia, and Akt signaling in both the retina and in cultured endothelial cells. TSP1 expression is correlated with the association of the CD36 receptor with Src versus Fyn. In the presence of TSP1, CD36 is coprecipitated with Fyn as previously shown by others. However, in the absence of TSP1, there is a preferential association with Src. We now demonstrate that these Src family kinases play an important role in modulating microvascular survival in response to TSP1 by crossing tsp1(-/-) mice to the src(-/-) and fyn(-/-) mice and testing the survival of retinal blood vessels in hyperoxia. We find that tsp1(-/-), fyn(-/-), and double-mutant tsp1(-/-)/fyn(-/-) mice have a similar enhancement of capillary survival in oxygen, whereas in a tsp(-/-) background, the loss of only one allele of src restores the balance in survival and apoptosis to that of wild-type mice. Taken together, we hypothesize that TSP1 antagonizes VEGF-driven Akt survival signaling in part through the recruitment of Fyn to membrane domains containing CD36, but when TSP1 is absent, an opposing Src recruitment contributes to VEGF-driven Akt phosphorylation and capillary survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304944      PMCID: PMC2685346          DOI: 10.1152/ajpheart.01246.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  42 in total

1.  Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.

Authors:  B P Eliceiri; R Paul; P L Schwartzberg; J D Hood; J Leng; D A Cheresh
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

2.  Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia.

Authors:  I Stein; A Itin; P Einat; R Skaliter; Z Grossman; E Keshet
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  CD36 associates with CD9 and integrins on human blood platelets.

Authors:  W M Miao; E Vasile; W S Lane; J Lawler
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

Review 4.  Thrombospondin 2, a matricellular protein with diverse functions.

Authors:  P Bornstein; L C Armstrong; K D Hankenson; T R Kyriakides; Z Yang
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

Review 5.  The cell biology of thrombospondin-1.

Authors:  H Chen; M E Herndon; J Lawler
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

6.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.

Authors:  B Jiménez; O V Volpert; S E Crawford; M Febbraio; R L Silverstein; N Bouck
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

7.  The association between CD36 and Lyn protein tyrosine kinase is mediated by lipid.

Authors:  Rick F Thorne; Estelle G Law; Craig A Elith; Kylie J Ralston; Richard C Bates; Gordon F Burns
Journal:  Biochem Biophys Res Commun       Date:  2006-10-06       Impact factor: 3.575

Review 8.  The functions of thrombospondin-1 and-2.

Authors:  J Lawler
Journal:  Curr Opin Cell Biol       Date:  2000-10       Impact factor: 8.382

9.  Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.

Authors:  Thuy L Phung; Keren Ziv; Donnette Dabydeen; Godfred Eyiah-Mensah; Marcela Riveros; Carole Perruzzi; Jingfang Sun; Rita A Monahan-Earley; Ichiro Shiojima; Janice A Nagy; Michelle I Lin; Kenneth Walsh; Ann M Dvorak; David M Briscoe; Michal Neeman; William C Sessa; Harold F Dvorak; Laura E Benjamin
Journal:  Cancer Cell       Date:  2006-08       Impact factor: 31.743

10.  Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo.

Authors:  Takuya Hatakeyama; Peter J Pappas; Robert W Hobson; Mauricio P Boric; William C Sessa; Walter N Durán
Journal:  J Physiol       Date:  2006-05-04       Impact factor: 5.182

View more
  28 in total

1.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

Authors:  David D Roberts; Thomas W Miller; Natasha M Rogers; Mingyi Yao; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

Review 3.  Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

Authors:  Patrick R Lawler; Jack Lawler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

4.  The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.

Authors:  Ding Li; Stacey D Finley
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

5.  Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.

Authors:  Shideh Kazerounian; Mark Duquette; Millys A Reyes; James T Lawler; Keli Song; Carole Perruzzi; Luca Primo; Roya Khosravi-Far; Federico Bussolino; Isaac Rabinovitz; Jack Lawler
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

Review 6.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

7.  Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice.

Authors:  Hiromitsu Hayashi; Keiko Sakai; Hideo Baba; Takao Sakai
Journal:  Hepatology       Date:  2012-03-18       Impact factor: 17.425

8.  Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Qi Zhou; Heather Norman; Changcheng Zhou; Shuxia Wang
Journal:  Biochim Biophys Acta       Date:  2015-03-31

9.  CD36 protein is involved in store-operated calcium flux, phospholipase A2 activation, and production of prostaglandin E2.

Authors:  Ondrej Kuda; Christopher M Jenkins; James R Skinner; Sung Ho Moon; Xiong Su; Richard W Gross; Nada A Abumrad
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

10.  Thrombospondins in the heart: potential functions in cardiac remodeling.

Authors:  Mark W M Schellings; Geert C van Almen; E Helene Sage; Stephane Heymans
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.